The Neuromuscular Junction

Slides:



Advertisements
Similar presentations
SYNAPSES AND DRUGS.
Advertisements

Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 16 Drugs That Block Nicotinic Cholinergic Transmission: Neuromuscular Blocking.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 15 Cholinesterase Inhibitors and Their Use in Myasthenia Gravis.
SHANNON KEHR PHYSIOLOGY APRIL 1, 2014 Muscle Relaxers.
Pharmacology of Cholinesterase Inhibitors and Nicotinic Antagonists
Skeletal Muscle Relaxants (Neuromuscular Blocking Agents)
How Does A Motor Unit Illicit A Muscular Contraction.
Synaptic transmission *** Synapse is the junction between two neurones where electrical activity of one neurone is transmitted to the other.
Neuromuscular Transmission synaptic transmission between a somatic motor neuron and a skeletal muscle fiber Somatic Fig
NEUROMUSCULAR JUNCTION DR. ZAHOOR ALI SHAIKH LECTURE
Skeletal muscle relaxants
Pharmacology-1 PHL 313 Parasympathetic Nervous System Sixth Lecture By Abdelkader Ashour, Ph.D. Phone:
Cellular Neuroscience (207) Ian Parker Lecture #13 – Postsynaptic excitation and inhibition.
Pharmacology DOR 101 Abdelkader Ashour, Ph.D. 5 th Lecture.
Skeletal muscle relaxants
NEUROMUSCULAR JUNCTION BLOCKERS BY :DR ISRAA OMAR.
MCMP 407 Spasmolytics Chronic neurologic diseases Cerebral Palsy, Multiple Sclerosis Acute Injury Spinal cord damage, muscle inflamation Goal of therapy:
Skeletal Muscle Relaxants
SKELETAL MUSCLE RELAXANTS
NEUROMUSCULAR BLOCKERS and CENTRAL MUSCLE RELAXANTS DR.ABDUL LATIF MAHESAR PHARMACOLOGY Dr.Alia Al-Shanawani December 17,2011 References: Basic and clinical.
PowerPoint ® Lecture Slides prepared by Janice Meeking, Mount Royal College C H A P T E R Copyright © 2010 Pearson Education, Inc. 11 Muscle Synapses Mike.
Cholinergic agonists & Cholinergic antagonists
Nerve Supply to Skeletal Muscle. Nerve Supply The outside of the nerve plasma membranes contain a slightly positive charge (Na+). The inside of this same.
Neuromuscular Junction (NMJ). Neuromuscular junction Neuromuscular junction : the synapse between motor neuron and muscle fibre Motor neurons : are the.
Pharmacology-1 PHL 351, Parasympathetic Nervous System Abdelkader Ashour, Ph.D. 6 th Lecture.
Neuromuscular transmission Motor Unit Motor Unit :Motor Unit : is the motor neuron and all the muscle fibers it supplies all of these fibers will have.
Today’s Objective: Neuromuscular Transmission
NEUROMUSCULAR JUNCTION BLOCKERS
1 Cholinergic Receptors Antagonists Section 2, lecture 3.
Skeletal muscle relaxants
11/22/20151 SKELETAL MUSCLE RELAXANTS. 211/22/2015 Classification on basis of site of action and mechanism of action A)PERIPHERALLY ACTING Neuromuscular.
SYNAPTIC & NEUROMUSCULAR TRANSMISSION Ass. Prof. Dr. Emre Hamurtekin EMU Faculty of Pharmacy.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 13 Drugs Affecting.
Pharmacology-1 PHL 211 Twelfth Lecture By Abdelkader Ashour, Ph.D. Phone:
Ch : Contraction and Metabolism of Skeletal Muscle
ANTICHOLINESTERASES Acetylcholinesterase is an enzyme that specifically cleaves acetylcholine to acetate and choline. It is located both pre-and post-synaptically.
Evolutionary pharmacology at the neuromuscular junction W. Rose.
Skeletal Muscle Relaxants
Neurophysiology II: The Synapse Synapse Defined Space between adjacent neurons! Relays information from one neuron to another! Neuron  Neuron Neuron.
Autonomic Nervous System 6-Anticholinergic Drugs
Dr: Samah Gaafar Al-shaygi بسم الله الرحمن الرحيم.
09.12 Function of the Neuromuscular Junction Slide number 1 Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
Chapter 13 Drugs Affecting Muscle Function Copyright © 2011 Delmar, Cengage Learning.
Nerve Supply to a Muscle. Nerve Supply Motor Neuron: Nerve that stimulates a muscle cell. A single nerve (motor neuron) will supply approximately 150.
(Cholinergic antagonists) (Anticholinergic ) (Cholinergic Blockers)
The Synapse A synapse is the functional connection between a neuron and a second cell. The second cell is also a neuron in CNS. In the PNS, the second.
Neuromuscular Blockers
Skeletal Muscle Blank.
Skeletal muscle relaxants
2. Striation Pattern of Sarcomere
Nerve MUSCLE PHYSIOLOGY
LECTURE 15 NEUROMUSCULAR JUNCTION
MUSCLE RELAXANTS Muscle relaxants are drugs that interrupt transmission of neural impulses at the neuromuscular junction.
Muscle Relaxants.
9 Muscles and Muscle Tissue: Part B.
Skeletal Muscle Relaxants
Anticholinesterase Drugs and Cholinergic Agonists
Cholinesterase Inhibitors (Indirect acting cholinergic agonists)
The Neuromuscular Junction
Skeletal Muscle Relaxants
SYNAPSES AND DRUGS.
Cholinergic Antagonist
Cholinergic Antagonist
SYNAPSES AND DRUGS.
Muscle Relaxants Dr Sura Al Zoubi
SYNAPSES AND DRUGS.
Functional Anatomy Excitatory Synapses Inhibitory Synapses
Skeletal muscle relaxants
Skeletal muscle relaxants
Cholinesterase inhibitors
Presentation transcript:

The Neuromuscular Junction

The Neuromuscular Junction: a Specialized form of synaptic transmission: communication between neurons and muscle

Major Events in Neuromuscular Transmission Motor neuron depolarization causes action potential to travel down the nerve fiber to the neuromuscular junction (1). Depolarization of the axon terminal causes an influx of Ca2+ (2) which triggers fusion of the synaptic vesicles (3) and release of neurotransmitter (Acetylcholine; ACh) (4). ACh diffuses across the synaptic cleft and binds to post-synaptic ACh receptor (AChR) located on the muscle fiber at the motor end-plate (5). Binding of ACh to AChRs opens the channels causing an influx of Na (5), depolarization of the sarcolemma that travels down the t-tubules (6) and ultimately causes the release of Ca2+ from the sarcoplasmic reticulum - CONTRACTION. Unbound ACh in synaptic cleft defuses away or is hydrolyzed (inactivated) by acetylcholinesterase (AChE) (7).

Transmitter Release at the Neuromuscular Junction Fig 13-7, Kandel, Schwartz, Jessel, 1991

Two main Types of Neuromuscular Blocking Drugs Nondepolarizing (competitive) Depolarizing

Mechanism of Action of Nondepolarizing Neuromuscular Blocking Drugs

Non-depolarizing (competitive). Prototype of Non-depolarizing is tubocurarine (new generation: pancuronium and gallamine). Mechanism of Action: In small clinical doses they act the predominantly at the nicotinic receptor site to block ACh. At higher does they can block prejunctional Na channels thereby decreasing ACh release. Because of the competitive nature of the postsynaptic blockade, transient relief of the block can be achieved by increasing ACh levels at the synaptic cleft (i.e. use cholinesterase inhibitors).

Nondepolarizing Agents Therapeutic Use: Adjuvant drugs in surgical anesthesia Pharmacology: Must be given by injection because they are poorly absorbed orally. Do not cross the BBB. Generally excreted unchanged (i.e. not metabolized). Adverse Effects: Tubocurarine causes release of histamine from mast cells – decrease in blood pressure, bronchospasms, skin wheals. Newer generation don’t.

Drug Interactions: Cholinesterase Inhibitors decrease the effectiveness of nondepolarizing agents Aminoglycoside antibiotics (e.g. streptomycin) decrease ACh release by competing with Ca2+ – increase action of nondepolarizing drugs Calcium channel blockers increase the actions of nondepolarizing drugs by decreasing the amount of ACh released (i.e. increase action of nondepolarizing drugs) Halogenated carbon anesthetics (e.g. Isoflurane) enhance neuromuscular blockade by 1) decreasing excitability of motoneurons, 2) increasing muscle blood flow, and 3) decreased kinetics of AChRs (increase action of nondepolarizing drugs)

Depolarizing Agents

Depolarizing Agents Prototype of depolarizing agent is succinylcholine (only depolarizing drug in clinical use). Mechanism of Action: Similar action to ACh, but longer acting. Phase 1: Membrane is depolarized by opening AChR channels causing brief period of muscle fasciculation. Phase II: End-plate eventually repolarizes, but because succinycholine is not metabolized like ACh it continues to occupy the AChRs to “desensitize” the end-plate. Because of the mechanism of action of depolazing drugs is similar to ACh, their blocking effects are augmented by AChE inhibitors.

Depolarizing Agents Therapeutic Use: Adjuvant drugs in surgical anesthesia Pharmacology: Duration of action is short (several minutes) because it is rapidly broken down by plasma cholinesterases (must be administered by continuous infusion) Adverse Effects: When administered with halothane some genetically susceptible people (inherited autosomal dominant condition) experience malignant hyperthermia. Treatment: rapid cooling of the body and dantrolene

Cholinesterase Inhibitors

Cholinesterase Inhibitors Examples: Neostigmine, edrophonium. Mechanism of Action: Inhibit acetylcholinesterase Therapeutic Use: Antidote for nondepolarizing blockers Treatment of myasthenia gravis (neostigmine) Diagnosis of myasthenia gravis (edrophonium)

Myasthenia Gravis                                               

Myasthenia Gravis is an autoimmune Disease that is characterized by a decrease in number of AChR Because there are fewer AChR to bind to the end plate potentials (EPPs) are smaller. With smaller EPPs the “safety factor” is reduced there is less chance that the post-synaptic muscle fibres will be activated

Note: The amplitude of the end plate-potential is directly related to the amount of ACh that binds to the post-synaptic AChRs.

Myasthenia Gravis

Adverse Effects Actions of generalized cholinergic activation (muscarinic and nicotinic). Abdominal cramping Diarrhea Flushing (transient redness of the face and neck) Increased salivation Miosis (contraction of the pupils) Incontinence Bronchospasms (can exacerbate bronchial asthma)

Malignant Hyperthermia Dantrolene (interferes with EC coupling by decreasing Ca exflux from the SR

Spasmolytic Drugs Diazepam (A Benzodiazepine that probably facilitates the actions of GABAA in the CNS) Baclofen (GABAB agonist – note error in your handouts) Primarily used in the treatment of spastiticy associated with spinal cord injury